[1]
A. M. Holbrook, E. M. Pullenayegum, S. M. Troyan, M. Nikitovic, and M. A. Crowther, “PERSONALIZED BENEFIT-HARM INFORMATION INFLUENCES PATIENT DECISIONS REGARDING WARFARIN”, J Popl Ther Clin Pharmacol, vol. 20, no. 3, Nov. 2018, Accessed: Nov. 19, 2024. [Online]. Available: https://mail.jptcp.com/index.php/jptcp/article/view/370